메뉴 건너뛰기




Volumn 95, Issue 2, 2002, Pages 228-235

Randomized trial comparing cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) with rotational CMF, epirubicin and vincristine as primary chemotherapy in operable breast carcinoma

Author keywords

Anthracycline containing regimen; Breast carcinoma; Cyclophosphomide, methotrexate, and 5 fluorouracil; Neoadjuvant chemotherapy; Primary chemotherapy; Randomized controlled trial

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; TAMOXIFEN; VINCRISTINE;

EID: 0037099558     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10678     Document Type: Article
Times cited : (6)

References (35)
  • 8
    • 0032547564 scopus 로고    scopus 로고
    • Polychemotherapy for early breast cancer: An overview of the randomized trials
    • Early Breast Cancer Trialists' Collaborative Group
    • (1998) Lancet , vol.352 , pp. 930-942
  • 14
    • 0025148099 scopus 로고
    • A comparison of continuation versus late intensification followed by discontinuation of chemotherapy in advanced breast cancer. A prospective randomized trial of the Italian Oncology Group for Clinical Research (GOIRC)
    • (1990) Ann Oncol , vol.1 , pp. 36-44
    • Cocconi, G.1    Bisagni, G.2    Bacchi, M.3
  • 21
    • 0030068274 scopus 로고    scopus 로고
    • Adjuvant cyclophosphamide, methotrexate, and fluorouracil versus fluorouracil, epirubicin, and cyclophosphamide chemotherapy in premenopausal women with axillary node-positive operable breast cancer: Results of a randomized trial
    • (1996) J Clin Oncol , vol.14 , pp. 35-45
    • Coombes, R.C.1    Bliss, J.M.2    Wils, J.3
  • 22
  • 23
    • 0002890387 scopus 로고    scopus 로고
    • CMF versus CAF with and without tamoxifen in high-risk node-negative breast cancer patients and a natural history follow-up study in low-risk node-negative patients: First results of intergroup trial INT 0102
    • (1998) Proc Am Soc Clin Oncol , vol.17
    • Hutchins, J.L.1    Green, S.2    Ravdin, P.3
  • 24
    • 0031927983 scopus 로고    scopus 로고
    • Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer
    • (1998) J Clin Oncol , vol.16 , pp. 2651-2659
    • Levine, M.1    Bramwell, V.2    Pritchard, K.I.3
  • 26
    • 0029926323 scopus 로고    scopus 로고
    • Adjuvant treatment of node-positive breast cancer with cyclophosphamide, doxorubicin, fluorouracil, and vincristine versus cyclophosphamide, methotrexate, and fluorouracil: Final report after a 16-year median follow-up duration
    • (1996) J Clin Oncol , vol.14 , pp. 1136-1145
    • Misset, J.L.1    Di Palma, M.2    Delgado, M.3
  • 29
    • 0034671601 scopus 로고    scopus 로고
    • Adjuvant doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in premenopausal women with axillary lymph node positive breast carcinoma. Results of a randomised controlled trial
    • (2000) Cancer , vol.89 , pp. 2521-2526
    • Bang, S.M.1    Heo, D.S.2    Lee, K.H.3
  • 30
    • 17944375163 scopus 로고    scopus 로고
    • HER-2 and topoisomerase IIalpha as predictive markers in a population of node-positive breast cancer patients randomly treated with adjuvant CMF or epirubicin plus cyclophosphamide
    • (2001) Ann Oncol , vol.12 , pp. 1081-1089
    • Di Leo, A.1    Larsimont, D.2    Gancberg, D.3
  • 31
    • 0025063119 scopus 로고
    • Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-non responsive tumors: Results from the National Surgical Adjuvant Breast and Bowel Project B-15
    • (1990) J Clin Oncol , vol.8 , pp. 1483-1496
    • Fisher, B.1    Brown, A.M.2    Dimitrov, N.V.3
  • 32
    • 0035865147 scopus 로고    scopus 로고
    • Tamoxifen and chemotherapy for axillary node-negative, estrogen receptornegative breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-23
    • (2001) J Clin Oncol , vol.19 , pp. 931-942
    • Fisher, B.1    Anderson, S.2    Tan-Chiu, E.3
  • 33
    • 0005856724 scopus 로고    scopus 로고
    • Adjuvant chemotherapy with high-dose epirubicin and cyclophosphamide (EC) versus cyclophosphamide, methotrexate, fluorouracil (CMF) in high risk premenopausal breast cancer patients (pts). A prospective randomized trial
    • (1997) Proc Am Soc Clin Oncol , vol.16
    • Galligioni, G.1    Cetto, G.2    Nascimben, O.3
  • 34
    • 4243291760 scopus 로고    scopus 로고
    • Adjuvant chemotherapy of breast cancer with 4 cycles of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) versus 4 cycles of doxorubicin and cyclophosphamide (AC) in equitoxic regimen. The comparative multicentric study
    • (1999) Proc Am Soc Clin Oncol , vol.18
    • Pribylova, O.1    Petruzelca, L.2    Fischer, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.